Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

This announcement is for information purposes only and does not constitute an invitation or offer to acquire, purchase or subscribe for any securities nor is it calculated to invite any such offer or invitation. In particular, this announcement does not constitute and is not an offer to sell or an invitation or a solicitation of any offer to buy or subscribe for any securities in Hong Kong, the United States of America or elsewhere. Securities may not be offered or sold in the United States of America absent registration or an exemption from registration under the United States Securities Act of 1933, as amended (the ''U.S. Securities Act''). The securities described herein have not been and will not be registered under the U.S. Securities Act. There will be no public offering of securities in the United States of America, the State of Israel or any jurisdiction other than Hong Kong.

Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from the United States of America or any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF SISRAM MEDICAL LTD ON THE MAIN BOARD OF

THE STOCK EXCHANGE OF HONG KONG LIMITED

RECORD DATE, CLOSURE OF THE REGISTER OF MEMBERS OF SHARES AND BASIS OF THE ASSURED ENTITLEMENT

OF QUALIFYING FOSUN INTERNATIONAL SHAREHOLDERS TO THE SISRAM SHARES

IN THE PREFERENTIAL OFFERING

The board of directors (the ''Board'') of Fosun International Limited (the ''Company'') is pleased to announce that the Record Date for the purpose of determining the Assured Entitlement of Qualifying Fosun International Shareholders to the Sisram Shares in the Preferential Offering will be Thursday, 31 August 2017. The register of members of the Company will be closed on Thursday, 31 August 2017 and no transfers of Shares will be registered on that date. The last day for dealing in the Shares cum-entitlement to the Assured Entitlement will be Monday, 28 August 2017.

As the final dates of registration and issue of the Prospectus have not yet been determined, the Record Date and the closure of the register of members of the Company for the purpose of determining the Assured Entitlement of Qualifying Fosun International Shareholders set out in this announcement are subject to change depending on the final timetable of the Proposed Spin-off and Listing.

The Board is also pleased to announce that it has determined the basis of the Assured Entitlement of Qualifying Fosun International Shareholders to the Sisram Shares in the Preferential Offering, if and when made. The basis of the Assured Entitlement is one (1) Sisram Share for every 1,560 Shares held by Qualifying Fosun International Shareholders on Thursday, 31 August 2017, being the Record Date.

The implementation of the Proposed Spin-off and Listing is subject to, among other things, the approval of the Hong Kong Stock Exchange, the final decisions of the Board and of the boards of directors of Fosun Pharma and Sisram as to whether to proceed with the Proposed Spin-off and Listing, which are subject to market conditions and pricing. Shareholders and potential investors of the Company should be aware that there is no assurance that the Proposed Spin-off and Listing will take place or as to when they may take place. If the Proposed Spin-off and Listing do not proceed for any reason, the Preferential Offering will not proceed.

Shareholders and potential investors of the Company should exercise caution when dealing in or investing in the securities of the Company. Any person who is in doubt about his/her/its position or any action to be taken is recommended to consult his/her/its own professional advisers.

  1. INTRODUCTION

    The Board refers to the announcement made by the Company on 6 June 2017 (the ''Announcement'') relating to the Proposed Spin-off and Listing. Unless the context otherwise requires, terms defined in the Announcement shall have the same meanings as those used in this announcement.

  2. RECORD DATE AND CLOSURE OF THE REGISTER OF MEMBERS OF SHARES

    As disclosed in the Announcement, the Company intends that if the Proposed Spin-off and Listing proceed, Qualifying Fosun International Shareholders will be provided with an Assured Entitlement to the Sisram Shares by way of a preferential application in the Global Offering.

    For the purpose of determining the Assured Entitlement of Qualifying Fosun International Shareholders to the Sisram Shares in the Preferential Offering and pursuant to Rule 13.66 of the Listing Rules, the Board announces that the Record Date will be Thursday, 31 August 2017. The register of members of the Company will be closed on Thursday, 31 August 2017 and no transfers of Shares will be registered on that date.

    In order to qualify for the Assured Entitlement, all transfers of Shares accompanied by the relevant share certificates must be lodged with the share registrar of the Company, Computershare Hong Kong Investor Services Limited, at Shops 1712-1716, 17th Floor, Hopewell Centre, 183 Queen's Road East, Wanchai, Hong Kong for registration by no later than 4: 30 p.m. on Wednesday, 30 August 2017. The last day for dealing in the Shares cum-entitlement to the Assured Entitlement will be Monday, 28 August 2017.

    As the final dates of registration and issue of the Prospectus have not yet been determined, the Record Date and the closure of the register of members of the Company for the purpose of determining the Assured Entitlement of Qualifying Fosun International Shareholders set out in this announcement are subject to change depending on the final timetable of the Proposed Spin-off and Listing.

    In the event that there is a change in the Record Date and the closure of the register of members of the Company for determining the Assured Entitlement of Qualifying Fosun International Shareholders, a further announcement will be made by the Company and such revised record date and closure of the register of members of Shares will supersede and replace the Record Date and the closure of the register of members of the Company for determining the Assured Entitlement of Qualifying Fosun International Shareholders set out in this announcement.

  3. BASIS OF THE ASSURED ENTITLEMENT OF QUALIFYING FOSUN INTERNATIONAL SHAREHOLDERS TO SISRAM SHARES IN THE PREFERENTIAL OFFERING

    The Board also announces that it has determined the basis of the Assured Entitlement of Qualifying Fosun International Shareholders to the Sisram Shares in the Preferential Offering, if and when made.

    The basis of the Assured Entitlement is one (1) Sisram Share for every 1,560 Shares held by Qualifying Fosun International Shareholders on Thursday, 31 August 2017, being the Record Date.

    The Assured Entitlement of Qualifying Fosun International Shareholders to the Sisram Shares is not transferable and there will be no trading in nil-paid entitlements on the Hong Kong Stock Exchange.

    Qualifying Fosun International Shareholders who hold at least 1,560 Shares on the Record Date and therefore have an Assured Entitlement to the Sisram Shares may apply for a number of Sisram Shares which is greater than, less than or equal to their Assured Entitlement under the Preferential Offering. A valid application for a number of Sisram Shares which is less than or equal to a Qualifying Fosun International Shareholder's Assured Entitlement under the Preferential Offering will be accepted in full, subject to the terms and conditions of the Preferential Offering.

    Qualifying Fosun International Shareholders who hold less than 1,560 shares on the Record Date and therefore will not have an Assured Entitlement to the Sisram Shares will still be entitled to participate in the Preferential Offering by applying for excess Sisram Shares only.

    Applications for excess Sisram Shares will only be satisfied to the extent that Sisram Shares made available to and not taken up by Qualifying Fosun International Shareholders as their Assured Entitlement under the Preferential Offering are sufficient to satisfy such excess applications.

    Qualifying Fosun International Shareholders should note that their Assured Entitlement to the Sisram Shares may not represent a full board lot of Sisram Shares. No odd lot matching services will be provided and dealings in odd lots of Sisram Shares may be at a price below the prevailing market price for full board lots.

    If the Preferential Offering proceeds, details of the Preferential Offering, including the terms and conditions for applications (including excess applications) for Sisram Shares under the Preferential Offering, will be set out in the Prospectus and the accompanying blue application form.

    As at the date of this announcement, the Company and Sisram have been advised by their PRC legal advisers that pursuant to Article 23 of the Implementation Rules for Registration, Depository and Clearing Services under the Mainland-Hong Kong Stock Markets Connect Programme

    ( 內地與香港股票市場交易互聯互通機制登記、存管、結算業務實施細則》), China Securities

    Depository and Clearing Corporation Limited does not provide services relating to the subscription of newly issued shares. Accordingly, even if the Preferential Offering proceeds, beneficial holders of Shares who hold Shares through Shanghai-Hong Kong Stock Connect or Shenzhen-Hong Kong Stock Connect cannot participate in the Preferential Offering and will not be able to take up their respective Assured Entitlement to the Sisram Shares under the Preferential Offering through the trading mechanism of Shanghai-Hong Kong Stock Connect or Shenzhen- Hong Kong Stock Connect.

  4. THE PROPOSED SPIN-OFF AND LISTING ARE SUBJECT TO MARKET CONDITIONS AND PRICING

The Board wishes to emphasize that, notwithstanding this announcement of the Record Date, the closure of the register of members of the Company and the basis of Assured Entitlement of Qualifying Fosun International Shareholders to the Sisram Shares in the Preferential Offering of the Company, the implementation of the Proposed Spin-off and Listing is subject to, among other things, the approval of the Hong Kong Stock Exchange and the final decisions of the Board and of the boards of directors of Fosun Pharma and Sisram as to whether to proceed with the Proposed Spin-off and Listing, which are subject to market conditions and pricing. The Board will only proceed with the Proposed Spin-off and Listing if the Board considers that the price of the Sisram Shares which can be obtained in the Global Offering, which is subject to market conditions, is such that proceeding with the Proposed Spin-off and Listing on those terms would be in the interests of the Company and the Shareholders as a whole.

Fosun International Limited published this content on 17 August 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 17 August 2017 13:21:03 UTC.

Original documenthttp://media.corporate-ir.net/media_files/IROL/19/194273/E00656_ann_0817_2000.pdf

Public permalinkhttp://www.publicnow.com/view/9E7850FCA36C98213BA0FAC39ADD2024799788B5